Recruiting

TEACHTelehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

Sponsor:

Intermountain Health Care, Inc.

Code:

NCT05141396

Conditions

Respiration, Artificial

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Telehealth- enabled support for SAT/SBT adherence

Usual audit and feedback for SAT/SBT adherence

Study Details

Brief summary:

The purpose of this trial is to evaluate if augmenting a usual audit and feedback implementation approach with telehealth-enabled support improves coordinated spontaneous awakening/breathing trials and patient outcomes for mechanically ventilated patients.

Conditions

Respiration, Artificial

Study ID

NCT05141396

Start date

Sep 1, 2022

Status verified date

Jun, 2023

Completion date

Oct 15, 2026

Anticipated

Primary completion date

Aug 31, 2026

Anticipated

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Inclusion criteria:

Patient age >=16 years admitted to study hospital ICU
Intubated and mechanically ventilated

Exclusion criteria:

Patient with pre-existing brain death admitted to study hospital for organ donation
Died within 24 hours of intubation

Study Design

Enrollment

13400 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherence

Usual audit and feedback + telehealth-enabled support

active comparator: Control - Usual audit/feedback for SAT/SBT adherence only

Usual audit and feedback

Interventions

Telehealth- enabled support for SAT/SBT adherence

Telehealth-enabled support over and above usual audit and feedback includes identifying candidates for spontaneous awakening and breathing trials, prompting bedside providers and guiding execution of the coordinated spontaneous awakening and breathing trials as needed.

Usual audit and feedback for SAT/SBT adherence

Usual audit and feedback

Primary outcome measure

Adherence to C-SAT/SBT [ Time Frame: intubation to extubation - an average of 5 days ]
Ventilator-free days to day 28 [ Time Frame: 28 days ]

Central Contacts and Locations

Central contacts

Carlos Barbagelata

8015074607 carlos.barbagelata@imail.org

Colin Grissom, MD

801-507-6554 colin.grissom@imail.org

Locations

American Fork Hospital

Recruiting

American Fork, Utah, United States, 84003

Principal Investigator:

David Guidry, MD

Cedar City Hospital

Recruiting

Cedar City, Utah, United States, 84721

Principal Investigator:

David Guidry, MD

Layton Hospital

Recruiting

Layton, Utah, United States, 84041

Principal Investigator:

David Guidry, MD

Logan Regional Hospital

Recruiting

Logan, Utah, United States, 84341

Principal Investigator:

David Guidry, MD

Intermountain Medical Center

Recruiting

Murray, Utah, United States, 84107

Contacts

Andrew Knighton

801-507-8714 Andrew.Knighton@imail.org

Principal Investigator:

Colin Grissom, MD

Mckay Dee Hospital

Recruiting

Ogden, Utah, United States, 84403

Principal Investigator:

Colin Grissom, MD

Utah Valley Hospital

Recruiting

Provo, Utah, United States, 84604

Principal Investigator:

Colin Grissom, MD

Riverton Hospital

Recruiting

Riverton, Utah, United States, 84065

Principal Investigator:

David Guidry, MD

St. George Regional Hospital

Recruiting

Saint George, Utah, United States, 84790

Principal Investigator:

Colin Grissom, MD

LDS Hospital

Recruiting

Salt Lake City, Utah, United States, 84143

Principal Investigator:

Colin Grissom, MD

Alta View Hospital

Recruiting

Sandy, Utah, United States, 84094

Principal Investigator:

David Guidry, MD

More Information

Sponsor

Intermountain Health Care, Inc.

Last update posted

Jul 3, 2023

Last verified

Jun, 2023

Keywords

Invasive Mechanical Ventilation
Coordinated Spontaneous Awakening and Breathing Trials

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Intermountain Health Care, Inc. on 2023-07-03.